MicroStrategy is on the verge of potentially joining the Nasdaq 100, possibly replacing Moderna, due to a remarkable surge in its stock driven by substantial investments in Bitcoin.

Analysts Eric Balchunas and James Seyffart anticipate that this inclusion could be announced as early as this Friday, with an official listing expected on December 23. This would represent a significant achievement for MicroStrategy, positioning it among the top 100 publicly traded companies in the U.S.

Currently categorized as a tech stock, MicroStrategy benefits from bypassing Nasdaq’s restrictions on financial firms. However, this classification may be reassessed in March, which could pose challenges for its inclusion.

Despite its heavy Bitcoin investments, which have led to a staggering 500% stock increase this year, Nasdaq still recognizes MicroStrategy as a tech entity, allowing it to meet the necessary criteria for index inclusion.

Balchunas emphasized that adding MicroStrategy to the Nasdaq 100 would highlight its growing influence, particularly in corporate Bitcoin adoption. Seyffart echoed this sentiment, noting that the primary concern remains the risk of reclassification. The final decision lies with Nasdaq, with an announcement anticipated soon.

This potential inclusion also reflects Nasdaq’s evolving stance towards cryptocurrency, hinting at a more welcoming approach to crypto-related companies.

Overall, MicroStrategy’s journey underscores Bitcoin’s transformative impact on traditional market dynamics, positioning it as a significant player in both the technology and cryptocurrency sectors.

Tags